Key result
Magnetic targeting of SPION-1 increases targeted arterial nanoparticle accumulation ~10-fold versus untargeted samples.
Why the study?
The behaviour of circulating SPIONs varies depending on nanoparticle characteristics, magnetic field strength, and flow dynamics, requiring an improved model to estimate magnetic capture under physiological-like conditions.
An ex vivo human umbilical artery model demonstrates that SPIONs with a lauric acid shell have the highest capacity for magnetic accumulation under flow conditions, suggesting potential for in vivo targeting to superficial arteries.
Lauric acid-coated SPIONs enable magnetic accumulation ex vivo; leaves open in vivo efficacy and safety for superficial artery targeting.
Magnetic targeting utilises the properties of superparamagnetic iron oxide nanoparticles (SPIONs) to accumulate particles in specified vasculature regions under an external magnetic field. As the behaviour of circulating particles varies depending on nanoparticle characteristics, magnetic field strength and flow dynamics, we established an improved ex vivo model in order to estimate the magnetic capture of SPIONs in physiological-like settings. We describe here a new, easy to handle ex vivo model of human umbilical artery. Using this model, the magnetic targeting of different types of SPIONs under various external magnetic field gradients and flow conditions was investigated by atomic emission spectroscopy and histology. Among tested particles, SPION-1 with lauric acid shell had the largest capacity to accumulate at the specific artery segment. SPION-2 (lauric acid/albumin-coated) were also successfully targeted, although the observed peak in the iron content under the tip of the magnet was smaller than for SPION-1. In contrast, we did not achieve magnetic accumulation of dextran-coated SPION-3. Taken together, the umbilical artery model constitutes a time- and cost-efficient, 3R-compliant tool to assess magnetic targeting of SPIONs under flow. Our results further imply the possibility of an efficient in vivo targeting of certain types of SPIONs to superficial arteries.
No takes yet. Share an insight, caveat, or question.
Janikowska et al. (2017) studied Ex vivo model for magnetic drug targeting (n=18). Magnetic targeting of SPIONs (SPION-1, SPION-2, SPION-3) vs. Untargeted samples (no magnetic field) was evaluated on Magnetic accumulation of SPIONs (iron concentration) at the specific artery segment under the magnet (>10-fold increase, p=<0.001). Magnetic targeting of SPION-1 with a lauric acid shell resulted in a greater than 10-fold increase in nanoparticle accumulation at the specific artery segment under the magnet compared to untargeted samples.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: